Spironolakton (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Spironolakton" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

9books.google.com

3^rd place

6^th place

7nih.gov

4^th place

13^th place

6web.archive.org

1^st place

4doi.org

2^nd place

4^th place

4worldcat.org

5^th place

7^th place

2drugs.com

399^th place

480^th place

2handle.net

102^nd place

411^th place

1aspetjournals.org

6,663^rd place

9,643^rd place

1doktersehat.com

low place

1,651^st place

1mshpriceguide.org

low place

aspetjournals.org

dmd.aspetjournals.org

Los LE, Pitzenberger SM, Ramjit HG, Coddington AB, Colby HD (1994). "Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites". Drug Metab. Dispos. 22 (6): 903–8. PMID 7895608.

books.google.com

NADIR R. FARID; Evanthia Diamanti-Kandarakis (27 February 2009). Diagnosis and Management of Polycystic Ovary Syndrome. Springer Science & Business Media. hlm. 235–. ISBN 978-0-387-09718-3.
Andrew Parkinson (2001). Biotransformation of Xenobiotics. McGraw-Hill. hlm. 137–138, 169, 171, 180, 195, 208.
Curtis D. Klaassen (11 December 2007). Casarett & Doull's Toxicology: The Basic Science of Poisons, Seventh Edition. McGraw Hill Professional. hlm. 173. ISBN 978-0-07-159351-9. Some P450 enzymes (such as the rate enzyme CYP2A1) preferentially catalyze the 6α-hydroxylation reaction, whereas other P450 enzymes (such as the CYP3A enzymes in all mammalian species) preferentially catalyze the 6β-hydroxylation reaction (which is a major route of hepatic steroid biotransformation).
Henry R. Black; William Elliott (28 December 2006). Hypertension: A Companion to Braunwald's Heart Disease. Elsevier Health Sciences. hlm. 295–. ISBN 978-1-4377-1078-6.
Maizes, Victoria (2015). Integrative Women's Health (edisi ke-2). hlm. 746. ISBN 9780190214807.
Prakash C Deedwania (30 January 2014). Drug & Device Selection in Heart Failure. JP Medical Ltd. hlm. 47–. ISBN 978-93-5090-723-8.
Eckhard Ottow; Hilmar Weinmann (9 July 2008). Nuclear Receptors As Drug Targets. John Wiley & Sons. hlm. 410. ISBN 978-3-527-62330-3. Diarsipkan dari versi asli tanggal 21 June 2013. Diakses tanggal 28 May 2012.
Camille Georges Wermuth (24 July 2008). The Practice of Medicinal Chemistry. Academic Press. hlm. 34. ISBN 978-0-12-374194-3. Diarsipkan dari versi asli tanggal 21 June 2013. Diakses tanggal 27 May 2012.
Marshall Sittig (1988). Pharmaceutical Manufacturing Encyclopedia. William Andrew. hlm. 1385. ISBN 978-0-8155-1144-1. Diarsipkan dari versi asli tanggal 20 June 2013. Diakses tanggal 27 May 2012.

doi.org

Sica, Domenic A. (2005). "Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis". Heart Failure Reviews. 10 (1): 23–29. doi:10.1007/s10741-005-2345-1. ISSN 1382-4147. PMID 15947888.
Carone, Laura; Oxberry, Stephen G.; Twycross, Robert; Charlesworth, Sarah; Mihalyo, Mary; Wilcock, Andrew (2017). "Spironolactone". Journal of Pain and Symptom Management. 53 (2): 288–292. doi:10.1016/j.jpainsymman.2016.12.320. ISSN 0885-3924. PMID 28024992.
Takamura, Norito; Maruyama, Toru; Ahmed, Shamim; Suenaga, Ayaka; Otagiri, Masaki (1997). "Interactions of Aldosterone Antagonist Diuretics with Human Serum Proteins". Pharmaceutical Research. 14 (4): 522–526. doi:10.1023/A:1012168020545. ISSN 0724-8741. PMID 9144743.
Draganov DI, La Du BN (January 2004). "Pharmacogenetics of paraoxonases: a brief review". Naunyn Schmiedebergs Arch. Pharmacol. 369 (1): 78–88. doi:10.1007/s00210-003-0833-1. hdl:2027.42/46312. PMID 14579013.

doktersehat.com

"Spironolactone: Manfaat, Dosis, dan Efek Samping". www.doktersehat.com. Diarsipkan dari versi asli tanggal 2020-07-16. Diakses tanggal 2020-07-14.

drugs.com

"Spironolactone". The American Society of Health-System Pharmacists. Diarsipkan dari versi asli tanggal 2015-11-16. Diakses tanggal Oct 24, 2015.
"Spironolactone Pregnancy and Breastfeeding Warnings". Diarsipkan dari versi asli tanggal 2 December 2015. Diakses tanggal 29 November 2015.

handle.net

hdl.handle.net

Draganov DI, La Du BN (January 2004). "Pharmacogenetics of paraoxonases: a brief review". Naunyn Schmiedebergs Arch. Pharmacol. 369 (1): 78–88. doi:10.1007/s00210-003-0833-1. hdl:2027.42/46312. PMID 14579013.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

mshpriceguide.org

"Spironolactone". International Drug Price Indicator Guide. Diakses tanggal 29 November 2015.

nih.gov

ncbi.nlm.nih.gov

Sica, Domenic A. (2005). "Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis". Heart Failure Reviews. 10 (1): 23–29. doi:10.1007/s10741-005-2345-1. ISSN 1382-4147. PMID 15947888.
Maron BA, Leopold JA (2008). "Mineralocorticoid receptor antagonists and endothelial function". Curr Opin Investig Drugs. 9 (9): 963–9. PMC 2967484 . PMID 18729003.
Carone, Laura; Oxberry, Stephen G.; Twycross, Robert; Charlesworth, Sarah; Mihalyo, Mary; Wilcock, Andrew (2017). "Spironolactone". Journal of Pain and Symptom Management. 53 (2): 288–292. doi:10.1016/j.jpainsymman.2016.12.320. ISSN 0885-3924. PMID 28024992.
Takamura, Norito; Maruyama, Toru; Ahmed, Shamim; Suenaga, Ayaka; Otagiri, Masaki (1997). "Interactions of Aldosterone Antagonist Diuretics with Human Serum Proteins". Pharmaceutical Research. 14 (4): 522–526. doi:10.1023/A:1012168020545. ISSN 0724-8741. PMID 9144743.
Los LE, Pitzenberger SM, Ramjit HG, Coddington AB, Colby HD (1994). "Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites". Drug Metab. Dispos. 22 (6): 903–8. PMID 7895608.
Draganov DI, La Du BN (January 2004). "Pharmacogenetics of paraoxonases: a brief review". Naunyn Schmiedebergs Arch. Pharmacol. 369 (1): 78–88. doi:10.1007/s00210-003-0833-1. hdl:2027.42/46312. PMID 14579013.
Friedman, Adam J. (1 October 2015). "Spironolactone for Adult Female Acne". Cutis. 96 (4): 216–217. ISSN 2326-6929. PMID 27141564.

web.archive.org

"Spironolactone". The American Society of Health-System Pharmacists. Diarsipkan dari versi asli tanggal 2015-11-16. Diakses tanggal Oct 24, 2015.
"Spironolactone: Manfaat, Dosis, dan Efek Samping". www.doktersehat.com. Diarsipkan dari versi asli tanggal 2020-07-16. Diakses tanggal 2020-07-14.
"Spironolactone Pregnancy and Breastfeeding Warnings". Diarsipkan dari versi asli tanggal 2 December 2015. Diakses tanggal 29 November 2015.
Eckhard Ottow; Hilmar Weinmann (9 July 2008). Nuclear Receptors As Drug Targets. John Wiley & Sons. hlm. 410. ISBN 978-3-527-62330-3. Diarsipkan dari versi asli tanggal 21 June 2013. Diakses tanggal 28 May 2012.
Camille Georges Wermuth (24 July 2008). The Practice of Medicinal Chemistry. Academic Press. hlm. 34. ISBN 978-0-12-374194-3. Diarsipkan dari versi asli tanggal 21 June 2013. Diakses tanggal 27 May 2012.
Marshall Sittig (1988). Pharmaceutical Manufacturing Encyclopedia. William Andrew. hlm. 1385. ISBN 978-0-8155-1144-1. Diarsipkan dari versi asli tanggal 20 June 2013. Diakses tanggal 27 May 2012.

worldcat.org

Sica, Domenic A. (2005). "Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis". Heart Failure Reviews. 10 (1): 23–29. doi:10.1007/s10741-005-2345-1. ISSN 1382-4147. PMID 15947888.
Carone, Laura; Oxberry, Stephen G.; Twycross, Robert; Charlesworth, Sarah; Mihalyo, Mary; Wilcock, Andrew (2017). "Spironolactone". Journal of Pain and Symptom Management. 53 (2): 288–292. doi:10.1016/j.jpainsymman.2016.12.320. ISSN 0885-3924. PMID 28024992.
Takamura, Norito; Maruyama, Toru; Ahmed, Shamim; Suenaga, Ayaka; Otagiri, Masaki (1997). "Interactions of Aldosterone Antagonist Diuretics with Human Serum Proteins". Pharmaceutical Research. 14 (4): 522–526. doi:10.1023/A:1012168020545. ISSN 0724-8741. PMID 9144743.
Friedman, Adam J. (1 October 2015). "Spironolactone for Adult Female Acne". Cutis. 96 (4): 216–217. ISSN 2326-6929. PMID 27141564.